Back to search

National and Kapodistrian University of Athens

Η επίδραση των βιολογικών παραγόντων θεραπείας ρευματικών νοσημάτων στη θυρεοειδική λειτουργία και η επαγωγή αυτοάνοσης θυρεοειδίτιδας

Abstract

dc:description

Biological anti-rheumatic agents (BAA) may induce autoimmune phenomena. Evidence on thyroid-specific effects of these agents is relatively limited. We studied prospectively, over 3 years, 36 rheumatic patients treated with BAA (18 Infliximab and 18 Rituximab) and no prior exposure to biological therapies (group-1), with respect to their thyroid function, thyroid antibody titers, and thyroid ultrasonographic parameters, such as left inferior thyroid artery peak systolic velocity (ITA PSV), left thyroid lobe vascularity index (TL VI), and echogenicity. Twenty-eight rheumatic patients treated with diseasemodifying anti-rheumatic drugs and/or glucocorticoids (group-2), 21 rheumatic patients not receiving any treatment (group-3), and 49 healthy individuals (group-4) were used for comparison. Thyroid function and autoantibody titers were not significantly altered at any stage irrespectively of the administered BAA, previously unknown autoimmune thyroid disease (AITD) status, and/or concomitant treatment with glucocorticoids. Left ITA PSV was significantly increased in group-1 patients (mean±SD start: 25.5±14.1 cm/s vs. end: 29.8±11.1 cm/s,p=0.038 and p=0.001, respectively). Six group-1, 7 group-2, and 3 group-3 patients developed reduced thyroid echogenicity during follow-up (start: p=0.003 and end: p=0.001). Left ITA PSV, left TL VI, and echogenicity changes were not related to alterations in thyroid volume, thyrotropin hormone levels, and/or underlying AITD. Infliximab and Rituximab do not cause any alterations in thyroid function and/or autoimmunity, even in patients with previously undiagnosed AITD. Elevated left ITA PSV and reduced thyroid echogenicity may be early features signaling progression to AITD in patients treated with BAA.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kaklamanos, Michail
  • Κακλαμάνος, Μιχαήλ

Subjects

dc:subject × 10

Rights

dc:rights
Statement dc:rights
  • BY
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/36662

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kaklamanos, Michail; Κακλαμάνος, Μιχαήλ. Η επίδραση των βιολογικών παραγόντων θεραπείας ρευματικών νοσημάτων στη θυρεοειδική λειτουργία και η επαγωγή αυτοάνοσης θυρεοειδίτιδας. National and Kapodistrian University of Athens, 2015. http://hdl.handle.net/10442/hedi/36662